Reference
Kratochwil C, et al. Targeted a-therapy of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617: Dosimetry estimate and empiric dose finding. Journal of Nuclear Medicine 58: 1624-1631, No. 10, Oct 2017. Available from: URL: http://doi.org/10.2967/jnumed.117.191395 - Germany
Rights and permissions
About this article
Cite this article
Cabazitaxel/docetaxel/PSMA 617. Reactions Weekly 1678, 49 (2017). https://doi.org/10.1007/s40278-017-38595-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-38595-8